Cerulean Pharma Fund Predictions

Buy CERU

*Your capital is at risk

$0.660

+0 (+0%)

At Close: Jan 16, 2018

Currently predicting for Fri, 5 Jun 2026

CERU Prediction Chart

CERU Predictions History

Latest community submissions for CERU.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
bbullish2 Merchant @bbullish2.7792	Jul 6, 2017	$0.712 -11.00%	$0.80	X	89.00%	0
JuanC Villegas Pro	Jul 5, 2017	$0.480 -57.52%	$1.13	X	42.50%	0
JS Pro	Jul 5, 2017	$0.472 -58.23%	$1.13	X	41.80%	0
bbullish2 Merchant @bbullish2.7792	Jul 5, 2017	$0.423 -62.57%	$1.13	X	37.40%	0
JS Pro	May 12, 2017	$0.445 -1.11%	$0.450	X	98.90%	1
JuanC Villegas Pro	May 12, 2017	$0.519 +15.33%	$0.450	X	84.70%	0
amrdonstock	May 12, 2017	$0.81 +79.56%	$0.450	X	20.40%	0
JS Pro	May 11, 2017	$0.520 +12.97%	$0.460	X	87.00%	0
JuanC Villegas Pro	May 11, 2017	$0.549 +19.27%	$0.460	X	80.70%	0
Michael.Moore.6256	Apr 28, 2017	$0.660 +18.92%	$0.560	V	81.10%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CERU with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CERULEAN PHARMA INC.

Cerulean Pharma Inc., a clinical-stage company, develops nanotechnology-based therapeutics in the areas of oncology and other diseases in the United States. The companys lead product candidate is CRLX101, a tumor targeted nanoparticle-drug conjugate (NDC), which is in Phase 2 clinical development in patients with renal cell carcinoma; and in Phase 2 and Phase 1b clinical development in patients with ovarian cancer. It is also developing CRLX301...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by